drugset / Trial / NCT02549768

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

NCT02549768 ↗

Phase 4 Unknown 40 enrolled Pontificia Universidad Catolica de Chile
RandomizedParallel-groupTriple-blindTreatment

Summary

Use of dexmedetomidine in pituitary tumor resection surgery as adjuvant drug and its relation to cortisol levels during postoperative period.

Timeline

Start
2015-09
Primary completion
2017-07
Completion
2017-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg —

Indications